Antiretroviral treatment and quality of life in Africans living with HIV: 12-month follow-up in Burkina Faso.

Abstract : Introduction: The scale-up of highly active antiretroviral therapy (HAART) has led to a significant improvement in survival of the HIV-positive patient but its effects on health-related quality of life (HRQOL) are less known and context-dependent. Our aim was to assess the temporal changes and factors associated with HRQOL among HIV-positive adults initiating HAART in Burkina Faso. Methods: HIV-positive people initiating HAART were prospectively included and followed over a one-year period in three HIV clinics of Ouagadougou. HRQOL was assessed at baseline and at each follow-up visit using physical (PHS) and mental (MHS) summary scores derived from the Medical Outcome Study 36-Item short-form health survey (MOS SF-36) questionnaire. Toxicity related to HAART modification and self-reported symptoms were recorded during follow-up visits. Determinants associated with baseline and changes in both scores over a one-year period were assessed using a mixed linear model. Results: A total of 344 patients were included. Their median age at baseline was 37 years [interquartile range (IQR) 30-44] and their median CD4 count was 181 cells/mm(3) (IQR 97-269). The mean [standard deviation (SD)] PHS score increased from 45.4 (11.1) at baseline to 60.0 (3.1) at 12 months (p < 10(-4)) and the mean (SD) MHS score from 42.2 (8.7) to 43.9 (3.4) (p<10(-2)). After one year of treatment, patients that experienced on average two symptoms during follow-up presented with significantly lower PHS (63.9) and MHS (43.8) scores compared to patients that presented no symptoms with PHS and MHS of 68.2 (p<10(-4)) and 45.3 (p<10(-3)), respectively. Discussion: The use of HAART was associated with a significant increase in both physical and mental aspects of the HRQOL over a 12-month period in this urban African population. Perceived symptoms experienced during follow-up visits were associated with a significant impairment in HRQOL. The appropriate and timely management of reported symptoms during the follow-up of HAART-treated patients is a key component to restore HRQOL.
Type de document :
Article dans une revue
J Int AIDS Soc, 2013, 16, pp.18867
Liste complète des métadonnées

Littérature citée [25 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-00924157
Contributeur : Antoine Jaquet <>
Soumis le : lundi 6 janvier 2014 - 14:24:06
Dernière modification le : mercredi 29 novembre 2017 - 14:54:12
Document(s) archivé(s) le : samedi 8 avril 2017 - 11:45:55

Fichier

 Accès restreint
Fichier visible le : jamais

Connectez-vous pour demander l'accès au fichier

Identifiants

  • HAL Id : inserm-00924157, version 1
  • PUBMED : 24369739

Collections

Citation

Antoine Jaquet, Franck Garanet, Eric Balestre, Didier Ekouevi, Jean Claude Azani, et al.. Antiretroviral treatment and quality of life in Africans living with HIV: 12-month follow-up in Burkina Faso.. J Int AIDS Soc, 2013, 16, pp.18867. 〈inserm-00924157〉

Partager

Métriques

Consultations de la notice

117